Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Frontiers in Cellular Neuroscience|August 21, 2018
Epigenetics Control Microglia PlasticityMathilde Cheray, Bertrand JosephEpigenomics|December 19, 2019
Epigenetic protein complexes: the adequate candidates for the use of a new generation of epidrugs in personalized and precision medicine in cancerPierre-François Cartron, Mathilde Cheray, Laurent BretaudeauFrontiers in Cellular Neuroscience|December 12, 2019
The Rules of Engagement: Do Microglia Seal the Fate in the Inverse Relation of Glioma and Alzheimer's Disease?Mathilde Cheray, Vassilis Stratoulias, Bertrand Joseph, et al.Nature Reviews. Neurology|March 11, 2021
Multifaceted microglia - key players in primary brain tumour heterogeneityLily Keane, Mathilde Cheray, Klas Blomgren, et al.Molecular Brain|June 4, 2021
Atg7 deficiency in microglia drives an altered transcriptomic profile associated with an impaired neuroinflammatory responseLara Friess, Mathilde Cheray, Lily Keane, et al.Cells|April 9, 2014
DNA methylation and apoptosis resistance in cancer cellsEric Hervouet, Mathilde Cheray, François Marie Vallette, et al.Clinical Epigenetics|July 2, 2013
Specific inhibition of one DNMT1-including complex influences tumor initiation and progressionMathilde Cheray, Romain Pacaud, Arulraj Nadaradjane, et al.Theranostics|January 2, 2015
Histone H3 phosphorylation in GBM: a new rational to guide the use of kinase inhibitors in anti-GBM therapyRomain Pacaud, Mathilde Cheray, Arulraj Nadaradjane, et al.Autophagy|February 28, 2022
ULK3-dependent activation of GLI1 promotes DNMT3A expression upon autophagy inductionPatricia González-Rodríguez, Mathilde Cheray, Lily Keane, et al.Epigenomics|August 12, 2014
Specific inhibition of DNMT1/CFP1 reduces cancer phenotypes and enhances chemotherapy effectivenessMathilde Cheray, Arulraj Nadaradjane, Pascal Bonnet, et al.Pageof 3